Bizarre Patents
Mouse device with a built-in printer
A mouse device for use as an input device of a computer is provided that includes a housing in which recording paper is loadable, and a printer unit provided within the housing for printing on the recording paper print information received from the computer.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7297659 | Synergistic fermented plant growth promoting, bio-control composition The present invention relates to a synergistic composition useful as plant and soil health enhancer, comprising urine, neem and garlic, individually or in all possible combinations, with the treatment showing it has the ability to stimulate accumulation of nutrients... | 11/20/2007 |
| 7232578 | Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof The present invention relates to a pharmaceutical composition for the treatment and prevention of cancer and the preparation method thereof, especially to a cell differentiation agent named CDA-II which is prepared by reverse phase chromatography of fresh human urin... | 06/19/2007 |
| 7192776 | Synthetic urine and method of manufacturing same A synthetic urine solution and method of its manufacture are disclosed. The solution includes water having a pH between 3 and 10. The solution further includes creatinine and means for removing bacteria from the solution so as to control or eliminate sepsis of the u... | 03/20/2007 |
| 6991784 | Selected mixture for animal lure The present invention is a lure optimized for a particular animal such as deer. The optimized lure is made using urine from only two animals urinating at approximately the same time. The animals can be either male or female, but preferably, females in estrus are use... | 01/31/2006 |
| 6926890 | Non-invasive approach for assessing tumors in living animals A means for following the growth of experimental neoplasms involves administering recombinant tumor cells containing an expression construct encoding a secretable marker to an experimental animal and measuring secreted marker in the urine of animals bearing tumors f... | 08/09/2005 |
| 6921751 | Immunoregulator The invention relates to the field of immunology. Specifically, the invention relates to the field of immune-mediated disorders such as allergies, auto-immune disease, transplantation-related disease or inflammatory disease. The invention provides for an immunoregul... | 07/26/2005 |
| 6855313 | Animal attractant The invention is basically an animal attractant that is made from human urine and animal urine. The attractant consists of a mixture of 14 to 15 parts male human urine 1 to 2 parts animal urine. The human urine is aged for two to three days. In the preferred embodim... | 02/15/2005 |
| 6805882 | Therapeutic fractions of sources of HCG The present invention relates to fractions of sources and or preparations of human chorionic gonadotropin, such as fractions of human early pregnancy urine, which fractions have anti-HIV activity. The present invention further relates to pharmaceutical compositions ... | 10/19/2004 |
| 6685929 | Viscous scent lure for hunting A viscous, non-liquid, non-gel scent lure for hunting, consisting of animal urine and a thickening agent. The thickening agent may comprise about 1% to about 7% by weight. The resulting viscosity of the solution ranges from about 1500 to about 10,000 cent... | 02/03/2004 |
| 6596688 | Method for promoting hematopoiesis The present invention relates to peptides of one or more portions of the human chorionic gonadotropin ଲ-chain as well as methods of promoting hematopoiesis, using human chorionic gonadotropin, employing the ଲ-chain of human chorionic gonadotro... | 07/22/2003 |
| 6583109 | Therapeutic polypeptides from ଲ-hCG and derivatives The present invention relates to peptides of one or more portions of the human chorionic gonadotropin ଲ-chain peptides containing a sequence of one or more portions of the ଲ-chain of human chorionic gonadotropin and derivatives and analogues t... | 06/24/2003 |
| 6569465 | Chemical alteration of mammal urine and mammal blood A method for chemical modification of mammal urine and mammal blood is disclosed.... | 05/27/2003 |
| 6531145 | Animal attractant, repellant and training scent product and method A method for luring animals, repelling animals and training animals and a product used therewith comprising microporous beads having animal attractant scents, animal repellant scents and animal training scents, respectively, imbibed within the beads. The ... | 03/11/2003 |
| 6458546 | Methods and reagents for preservation of DNA in bodily fluids A method and system are provided for preserving nucleic acids in a bodily fluid, such as urine, blood, blood serum, and amniotic fluid. The preservative includes an amount of a divalent metal chelator selected from ethylenediaminetetraacetic acid (EDTA), ... | 10/01/2002 |
| 6303154 | Chemical alteration of mammal urine and mammal blood A method for chemical modification of mammal urine and mammal blood is disclosed.... | 10/16/2001 |
| 6303152 | Process for the production of substances that have been bactericidally treated and/or exhibit immune-modulatory activity, and the use thereof A process is disclosed for the production of immune-genetically active suspensions of which the initial substances are fluids or tissues from the human or animal body. Autohemotherapy, immune-stimulatory and/or immune-suppressive effects are employed. The... | 10/16/2001 |
| 6274550 | Azaftig, a proteoglycan for monitoring cachexia and for control of obesity A proteoglycan ("azaftig") with a molecular weight of approximately 24,000 Dalton has been isolated and partially characterized from the urine of cachectic cancer and non-cancer patients. Azaftig has been shown to bind to receptors on fat cell membranes, ... | 08/14/2001 |
| 6231849 | Simulated seminal fluid The simulation of mammalian male reproductive secretions or seminal fluids by specific odoriferous chemical compounds comprised of 1-Methyl Pyrrolidine, 1-Methyl-2-Pyrrolidine Methanol, 1-Methyl-2 Pyrrolidine Ethanol, Pyrrolidine and 2-Pyrrolidone either ... | 05/15/2001 |
| 6149901 | Animal scent enhancer The present invention relates to animal scent attractants. More particularly, the present invention relates to a composition of matter for amplifying and preserving animal scents. Fox urine, coyote urine, deer urine, elk urine, moose urine, bear urine, ra... | 11/21/2000 |
| 6010721 | Glycyrrhetinic-acid-like factor A human glycyrrhetinic-acid-like factor which inhibits certain enzymes in pathways of steroid hormone degradation is disclosed.... | 01/04/2000 |
| 5916552 | Deer urine attractant composition method of making and using A semi-solid deer attractant lure comprised of liquid deer urine plus a sufficient amount of flavorless gelatin to produce a semi-solid rubbery composition is disclosed. Also disclosed is a method of making and a method of using the deer attractant lure c... | 06/29/1999 |
| 5834028 | Soluble thrombomodulin-containing composition The present invention is directed to a soluble thrombomodulin-containing composition comprising at least one molecular species of soluble thrombomodulin, and at least one member selected from the group consisting of maltose, lactose, sucrose, arginine and... | 11/10/1998 |
| 5783555 | Ulinastatin-containing suppository Ulinastatin-containing suppository is produced by emulsifying an aqueous solution of ulinastatin in an oily base uniformly in the presence of an emulsifier and then solidifying the emulsion. The ulinastatin-containing suppository exhibits high stability even i... | 07/21/1998 |
| 5723438 | Method of antiviral use of soluble LDL receptor A soluble LDL receptor protein is provided. It can be isolated from cells that have been treated with an interferon, isolated from the urine of healthy human individuals or produced by recombinant techniques. The soluble LDL receptor protein is useful in ... | 03/03/1998 |
| 5690964 | Non-toxic rodent deterrent A non-toxic rodent deterrent made from dried fecal matter and/or dried urine from mammals of the Mustelidae Family (e.g. weasels, ferrets, minks, martens, etc.). The rodent deterrent material may be used in its bulk from or this material may be placed in ... | 11/25/1997 |
| 5476922 | Methods and compositions for the preparation and use of autocrine growth factors Autocrine growth factors and isoforms of those factors have been identified, isolated, purified and manipulated. Nucleic acid segments coding for the factors, and antibodies directed to the factors are also aspects of the present invention. The effect of ... | 12/19/1995 |
| 5427781 | Method of activating T cells with lymphokine SAF A lymphokine is taught which can be used to activate and stimulate CD3+, CD4+ T cells, as well as Sezary leukemic T cells. The lymphokine can be obtained from mitogen-stimulated peripheral blood mononuclear cells or urine of Sezary S... | 06/27/1995 |
| 5422393 | Natriuretic hormone A purified naturally occurring natriuretic compound, identified as Natriuretic Hormone, and a method for isolation of the compound. The natriuretic compound has a molecular weight of about 360, a molecular formula of C21 H28 O5 | 06/06/1995 |
| 5240714 | Non-digoxin-like Na+, K+ -ATPase inhibitory factor A highly purified, Na+,K+ -ATPase inhibitory factor is disclosed herein. The factor does not cross-react with anti-digoxin antibody and exhibits uniquely characteristic UV absorbance maxima at approximately 202-210 nm and at 274-280 ... | 08/31/1993 |
| 5116622 | Methods for treating Parkinson's disease The present invention provides methods for treating Parkinson's disease by administering to an afflicted host pharmaceutical compositions containing a therapeutically effective amount of urine peptide fractions containing 3-[N-phenylacetylaminopiperidine]... | 05/26/1992 |
| 5106630 | Natriuretic hormone A purified naturally occurring natriuretic compound, identified as Natriuretic Hormone, and a method for isolation of the compound. The natriuretic compound has a molecular weight of about 360, a molecular formula of C21 H28 O5 | 04/21/1992 |
| 5104639 | Method for biological testing and/or developing pharmaceuticals for treatment of disorders using electrochromatography A method for establishing a treatment protocol for correcting an abnormal condition or disease in a living organism is described. The method comprises the steps of analyzing body fluids from normal and abnormal individuals to generate analysis patterns of... | 04/14/1992 |
| 4950465 | Pharmaceutical composition for relieving side effects of platinum-containing drugs A pharmaceutical composition for relieving side effects of platinum-containing drugs, containing an effective component of ulinastatin is provided. The platinum-containing drugs such as cisplatinum cause serious side effects including kidney dysfunction. ... | 08/21/1990 |
| 4891356 | Proteinase inhibitors for treatment of gastrointestinal ulcer disease A method of treating gastrointgestinal ulcer disease is provided which involves administration of a proteinase inhibitor or analogue to patients suffering from same. Of particular interest is the use of inhibitors of serine, cysteine, carboxyl, and metall... | 01/02/1990 |
| 4818535 | Repellent compositions A repellent composition e.g. for repelling deer comprises a synthetic blend of components which are characteristic of the acid fraction obtained by a Soxhlet extraction of lion faeces followed by separation into basic, neutral and acid fractions; and feli... | 04/04/1989 |
| 4780314 | Isolation and purification of a digitalis-like factor This invention relates to a novel recovery process for obtaining the small molecular weight, digitalis-like factor, and further relates to purification of the digitalis-like factor. This invention also relates to the identification and characterization of... | 10/25/1988 |
| 4620908 | Method for destroying microbial contamination in protein materials A method for destroying microbial contamination, such as viral and bacterial contamination and mycoplasma contamination, in protein material, and particularly tissue and serum from animals and human beings. The method comprises the reducing of the tempera... | 11/04/1986 |
| 4595588 | Natural inhibitor that protects against viral infections A treatment and prophylaxis of viral infections in mammals is provided. The method involves administering an amount of a contact-blocking viral inhibitor (CVI) sufficient to elevate the concentration of the viral inhibitor in the mammal's tissue above the... | 06/17/1986 |
| 4500514 | Process for preparing a heat-stable aqueous solution of human urine kallikrein and product prepared Human urine kallikrein dissolved in water is made heat-stable by the addition of a citric acid salt such as sodium citrate, so that an aqueous solution containing the kallikrein and the citric acid salt can be sterilized at 60° to 70° C.... | 02/19/1985 |
| 4482485 | Method of preparation of human urine origin colony-stimulating factor and kallikrein Human urine-origin colony-stimulating factor and kallikrein are separated in pure form, respectively, from an aqueous solution thereof, such as a urinary protein-concentrated solution by subjecting the solution added with a stabilizer such as octyl-phenox... | 11/13/1984 |
